Overview

Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
0
Participant gender:
All
Summary
The optimal strategy to restore sinus rhythm in patients with atrial fibrillation (AF) of less than 48 hours' duration is still controversial. The investigators performed a controlled single-center trial to compare electrical and pharmacological (propafenone) cardioversion to restore the sinus rhythm in selected patients with acute atrial fibrillation.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Valduce Hospital
Treatments:
Propafenone
Criteria
Inclusion Criteria:

- atrial fibrillation of less than 48 hours' duration.

Exclusion Criteria:

- AF of more than 48 hours'

- hemodynamic instability

- acute onset atrial fibrillation due to acute coronary syndrome

- electrolyte disturbances

- sepsis

- fever

- hypothermia

- untreated hyperthyroidism

- use of antiarrhythmic drugs

- high embolic risk

- unclear duration of symptoms